Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Gamma-Aminobutyric Acid and Formalin

Research Papers that Mention the Interaction

The levels of GAD expression and GABA concentration decreased after formalin injection and were increased by P7C3.
European journal of pharmacology  •  2021  |  View Paper
GABA levels in the dorsal periaqueductal gray were lower in rats receiving intraplantar injection of formalin , compared with saline-treated controls.
The journal of pain : official journal of the American Pain Society  •  2009  |  View Paper
Likewise, formalin increased glutamate and produced a biphasic response on GABA.
European journal of pharmacology  •  2006  |  View Paper
Microinjection of GABA to PAG significantly increased these behavioural responses to formalin.
Neuroscience Letters  •  2001  |  View Paper
Microinjection of GABA to GiA increased the behavioural response to formalin between 10 and 20 min post‐injection, while microinjection of DLH reduced this response at all time points except 10 min post‐injection (n=8, P<0.05, Mann–Whitney U‐test).
Microinjection of GABA to GiA significantly increased the behavioural response to formalin from 20 to 50 min post‐injection.
Pain  •  2001  |  View Paper
Both glutamate and GABA release decreased after the injection of formalin during phase I and phase II of hyperalgesia.
Neuroreport  •  1999  |  View Paper
However, approximately … injury by formalin, … GABA and activation of GABA(A) receptors in the spinal cord that 1) contributes to the period of quiescence between phase 1 and … diminishes the magnitude of pain behaviors in phase 2, possibly by limiting the development of central sensitization in the spinal cord.
The Journal of pharmacology and experimental therapeutics  •  1997  |  View Paper